Stock SILK SILK ROAD MEDICAL, INC
Add to a list
To use this feature you must be a member
Log inSign up

Company Silk Road Medical, Inc

Equities

SILK

US82710M1009

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX
Other stock markets
 02:38:27 2024-04-30 pm EDT 		5-day change 1st Jan Change
19.4 USD +2.65% Intraday chart for Silk Road Medical, Inc +9.82% +58.15%
Apr. 02 Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus CI
Mar. 08 North American Morning Briefing : Stock Futures -2- DJ

Business Summary

Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.

Number of employees: 474

Sales per Business

USD in Million2022Weight2023Weight Delta
Transcarotid Artery Revascularization
100.0 %
139 100.0 % 177 100.0 % +27.77%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
139 100.0 % 177 100.0 % +27.77%

Managers

Managers TitleAgeSince
Charles McKhann CEO
 Chief Executive Officer 55 Nov. 01
Lucas Buchanan DFI
 Director of Finance/CFO 46 09-07-31
William Whealon CTO
 Chief Tech/Sci/R&D Officer - 20-09-20
Tammy Leitsinger CMP
 Compliance Officer - 16-12-31
Sumaira Macdonald CTO
 Chief Tech/Sci/R&D Officer - 14-01-12
Julia Anastas LAW
 General Counsel - 20-04-30
Frances Versprille PRN
 Corporate Officer/Principal - -
Jeremy Wright PRN
 Corporate Officer/Principal - 15-06-30
Alison Highlander HRO
 Human Resources Officer - 16-12-31
Andrew Davis PRN
 Corporate Officer/Principal 55 15-05-27

Members of the board

Members of the board TitleAgeSince
Don Zurbay BRD
 Director/Board Member 56 18-03-25
Kevin Ballinger BRD
 Director/Board Member 51 20-12-02
Jack Lasersohn CHM
 Chairman 70 07-03-31
Elizabeth Weatherman BRD
 Director/Board Member 64 13-03-31
Rick Anderson BRD
 Director/Board Member 63 20-09-30
Tony M. Chou FOU
 Founder 63 07-02-28
Tanisha Cariño BRD
 Director/Board Member 49 21-07-21
Charles McKhann CEO
 Chief Executive Officer 55 Nov. 01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 39,441,919 36,849,713 ( 93.43 %) 0 93.43 %

Shareholders

NameEquities%Valuation
Wasatch Advisors, Inc.
11.61 %
4,549,742 11.61 % 83 M $
Capital Research & Management Co. (World Investors)
7.573 %
2,966,730 7.573 % 54 M $
BlackRock Advisors LLC
7.443 %
2,915,678 7.443 % 53 M $
Vanguard Fiduciary Trust Co.
7.382 %
2,891,769 7.382 % 53 M $
Goldman Sachs Asset Management LP
5.133 %
2,010,983 5.133 % 37 M $
Jefferies Financial Group Inc. (Investment Management)
4.866 %
1,906,236 4.866 % 35 M $
Armistice Capital LLC
4.513 %
1,768,000 4.513 % 32 M $
Morgan Stanley Investment Management, Inc.
4.407 %
1,726,408 4.407 % 32 M $
D.E. Shaw & Co., Inc.
3.839 %
1,503,752 3.839 % 28 M $
Bellevue Asset Management AG
3.665 %
1,435,682 3.665 % 26 M $

Company contact information

Silk Road Medical, Inc.

1213 Innsbruck Drive

94089, Sunnyvale

+408 720 9002

http://www.silkroadmed.com
address Silk Road Medical, Inc(SILK)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Ratings for Silk Road Medical, Inc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
18.9 USD
Average target price
18.43 USD
Spread / Average Target
-2.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SILK ROAD MEDICAL, INC Stock Silk Road Medical, Inc
+54.03% 745M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.54% 186B
MEDTRONIC PLC Stock Medtronic plc
-1.85% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.26% 67.44B
DEXCOM, INC. Stock DexCom, Inc.
+1.39% 50.03B
CENCORA, INC. Stock Cencora, Inc.
+16.82% 47.81B
HOYA CORPORATION Stock Hoya Corporation
+4.79% 41.03B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.49% 26.85B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.65% 25.82B
TERUMO CORPORATION Stock Terumo Corporation
+16.55% 24.74B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. SILK Stock
  4. Company Silk Road Medical, Inc